Medivir AB (MVR0) Financial Statements
Medivir AB Financial Overview
Medivir AB's market cap is currently $88.26M. The company's EPS TTM is ―; its P/E ratio is -3.54; Medivir AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | ― | ― | $ 13.95M | ― | ― |
| Operating Income | $ -88.61M | $ -64.40M | $ -55.68M | $ -128.59M | $ -351.03M |
| EBITDA | $ -85.27M | $ -59.03M | $ -37.64M | $ -114.93M | $ -324.16M |
| Net Income | $ -88.77M | $ -63.13M | $ -42.62M | $ -123.44M | $ -350.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 234.20M | $ 335.82M | $ 191.46M | $ 293.46M | $ 419.35M |
| Total Debt | $ 15.51M | $ 14.02M | $ 16.49M | $ 43.88M | $ 0.00 |
| Net Debt | $ -101.92M | $ -207.15M | $ -53.52M | $ -90.63M | $ -286.28M |
| Total Liabilities | $ 41.41M | $ 54.68M | $ 49.56M | $ 109.01M | $ 111.75M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -102.20M | $ -48.73M | $ -60.74M | $ -149.69M | $ -325.47M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD
